CYP19A1 and Familial prostate cancer: For example, naringenin inhibits the activity of aromatase (CYP19) in Chinese hamster ovary (CHO) cells, thereby decreasing estrogen biosynthesis and inducing antiestrogenic effects, which are important in breast and prostate cancers [35].